Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 18055 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 19760 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 23164 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 24112 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 28663 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 29542 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 33686 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 34036 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 35977 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 36552 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 40082 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 40268 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 41367 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 42141 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 46456 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 49951 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 51861 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 52454 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 53723 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 56511 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 58539 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 70219 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 74624 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 90376 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 94719 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (M-H)- | 102457 | Peak area normalized | female | Pre-diabetic | Neuropathy |